Hospitals lose 10–20% of Medical supply procurement value due to lack of visibility, especially in high-usage injections like Ceftriaxone (Inj. GenCeft) and Cefoperazone-Sulbactam (Inj. GenCepS).
Where the Loss Happens
| Area | Impact |
| Rate variation | 8–20% |
| Expiry loss | 2–6% |
| Duplicate ordering | 3–8% |
| Financial mismatch | 2–5% |
High-Impact Antibiotic Injections
- Inj. GenCeft → High volume
- Inj. GenCepS / Forte → Frequent use
- Inj. GenPiptaz → ICU usage
- Inj. GenMero → High-value
Why It Remains Invisible
- No centralized tracking
- No rate comparison
- No structured system
Reality
Everything is functioning.
But nothing is being measured.
Our Mission
To make medicine procurement:
- Visible
- Structured
- Measurable
System Gap
Hospitals already have:
- Doctors
- Vendors
- Supply
Missing part of medical supply?
Clarity over all medical supply decisions
A procurement simplification system:
- Tracks antibiotic injections
- Shows rate variation
- Reduces expiry
- Standardizes usage
Hospitals do not pay to use the system.
Value is generated through optimized antibiotic injection usage.
The biggest loss in hospitals is not clinical.
It is invisible operational loss in antibiotic injections due to lack of visibility.